Coca-Cola saw the highest growth of 116% in patent filings in January and 118% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 116% and grants by 106%. GlobalData’s DataBook provides a comprehensive analysis of Coca-Cola’s patent filings and grants. Buy the databook here.
Coca-Cola has been focused on protecting inventions in European Patent Office(EPO) with 26 publications in Q1 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 20% filings and 27% grants. The European Patent Office(EPO), United States(US), China(CN), and Japan(JP) patent Office are among the top ten patent offices where Coca-Cola is filings its patents. Among the top granted patent authorities, Coca-Cola has 27% of its grants in European Patent Office(EPO), 24% in United States(US) and 16% in South Korea(KR).
DSM-Firmenich and Nestle could be the strongest competitors for Coca-Cola
Patents related to health & wellness and genetically modified organism (GMO) lead Coca-Cola's portfolio
Coca-Cola has the highest number of patents in health & wellness followed by, genetically modified organism (GMO) and meat & seafood alternatives. For health & wellness, nearly 26% of patents were filed and 8% of patents were granted in Q1 2024.
Non-alcoholic beverages related patents lead Coca-Cola portfolio followed by soft drinks, and sweeteners
Coca-Cola has highest number of patents in non-alcoholic beverages followed by soft drinks, sweeteners, packaging, and food. For non-alcoholic beverages, nearly 26% of patents were filed and 11% of patents were granted in Q1 2024.
For comprehensive analysis of Coca-Cola's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.